{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T08:07:44Z","timestamp":1790150864103,"version":"4.0.1"},"reference-count":31,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,4,12]],"date-time":"2019-04-12T00:00:00Z","timestamp":1555027200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"DOI":"10.3389\/fphar.2019.00378","type":"journal-article","created":{"date-parts":[[2019,4,12]],"date-time":"2019-04-12T04:28:33Z","timestamp":1555043313000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":15,"title":["Mycolactone as Analgesic: Subcutaneous Bioavailability Parameters"],"prefix":"10.3389","volume":"10","author":[{"given":"J\u00e9r\u00e9mie","family":"Babonneau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitri","family":"Br\u00e9ard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Line","family":"Reynaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Estelle","family":"Marion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Guilet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Paul","family":"Saint Andr\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Crou\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priscille","family":"Brodin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Richomme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Marsollier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,4,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2885","DOI":"10.1084\/jem.20160662","article-title":"Mycolactone subverts immunity by selectively blocking the sec61 translocon.","volume":"213","author":"Baron","year":"2016","journal-title":"J. Exp. Med."},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3008320","article-title":"Lost but making progress-Where will new analgesic drugs come from?","volume":"6","author":"Borsook","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0002618","article-title":"Accelerated detection of mycolactone production and response to antibiotic treatment in a mouse model of Mycobacterium ulcerans disease.","volume":"8","author":"Converse","year":"2014","journal-title":"PLoS Negl. Trop. Dis."},{"key":"B4","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1177\/2049463713507439","article-title":"Pharmacogenetics of analgesic drugs.","volume":"7","author":"Cregg","year":"2013","journal-title":"Br. J. Pain"},{"key":"B5","doi-asserted-by":"publisher","first-page":"2002","DOI":"10.1128\/IAI.01588-07","article-title":"Mycolactone is responsible for the painlessness of Mycobacterium ulcerans infection (buruli ulcer) in a murine study.","volume":"76","author":"En","year":"2008","journal-title":"Infect. Immun."},{"key":"B6","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1126\/science.283.5403.854","article-title":"Mycolactone: a polyketide toxin from Mycobacterium ulcerans required for virulence.","volume":"283","author":"George","year":"1999","journal-title":"Science"},{"key":"B7","doi-asserted-by":"publisher","first-page":"805","DOI":"10.2353\/ajpath.2006.050375","article-title":"Nerve damage in Mycobacterium ulcerans-infected mice: probable cause of painlessness in buruli ulcer.","volume":"168","author":"Goto","year":"2006","journal-title":"Am. J. Pathol."},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aab0458","article-title":"Shaping mycolactone for therapeutic use against inflammatory disorders.","volume":"7","author":"Guenin-Mac\u00e9","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"B9","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1042\/BST20130133","article-title":"Pleiotropic molecular effects of the Mycobacterium ulcerans virulence factor mycolactone underlying the cell death and immunosuppression seen in buruli ulcer.","volume":"42","author":"Hall","year":"2014","journal-title":"Biochem. Soc. Trans."},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1004061","article-title":"The pathogenic mechanism of the Mycobacterium ulcerans virulence factor, mycolactone, depends on blockade of protein translocation into the ER.","volume":"10","author":"Hall","year":"2014","journal-title":"PLoS Pathog."},{"key":"B11","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/0304-3959(88)90026-7","article-title":"A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia.","volume":"32","author":"Hargreaves","year":"1988","journal-title":"Pain"},{"key":"B12","doi-asserted-by":"publisher","first-page":"2822","DOI":"10.1039\/b308163j","article-title":"Identification using LC-MSn of co-metabolites in the biosynthesis of the polyketide toxin mycolactone by a clinical isolate of Mycobacterium ulcerans.","volume":"21","author":"Hong","year":"2003","journal-title":"Chem. Commun."},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0006058","article-title":"Mycolactone displays anti-inflammatory effects on the nervous system.","volume":"11","author":"Isaac","year":"2017","journal-title":"PLoS Negl. Trop. Dis."},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0020108","article-title":"Buruli ulcer (M. ulcerans infection): new insights, new hope for disease control.","volume":"2","author":"Johnson","year":"2005","journal-title":"PLoS Med."},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofw013","article-title":"Clinical features of spontaneous partial healing during Mycobacterium ulcerans infection.","volume":"3","author":"Marion","year":"","journal-title":"Open Forum Infect. Dis."},{"key":"B16","doi-asserted-by":"publisher","first-page":"2690","DOI":"10.4049\/jimmunol.1502194","article-title":"FVB\/N mice spontaneously heal ulcerative lesions induced by Mycobacterium ulcerans and switch M. ulcerans into a low mycolactone producer.","volume":"196","author":"Marion","year":"","journal-title":"J. Immunol."},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0033600","article-title":"Photodegradation of the Mycobacterium ulcerans toxin, mycolactones: considerations for handling and storage.","volume":"7","author":"Marion","year":"2012","journal-title":"PLoS One"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1016\/j.cell.2014.04.040","article-title":"Mycobacterial toxin induces analgesia in buruli ulcer by targeting the angiotensin pathways.","volume":"157","author":"Marion","year":"2014","journal-title":"Cell"},{"key":"B19","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/S0924-8579(03)00240-1","article-title":"Susceptibility of Mycobacterium ulcerans to a combination of amikacin\/rifampicin.","volume":"22","author":"Marsollier","year":"2003","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B20","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/nrd3226","article-title":"Pain market.","volume":"9","author":"Melnikova","year":"2010","journal-title":"Nat. Rev. Drug. Discov."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1074\/mcp.RA118.000824","article-title":"Proteomics reveals scope of mycolactone-mediated sec61 blockade and distinctive stress signature.","volume":"17","author":"Morel","year":"2018","journal-title":"Mol. Cell. Proteo."},{"key":"B22","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/s41419-018-0427-y","article-title":"Inhibition of Sec61-dependent translocation by mycolactone uncouples the integrated stress response from ER stress, driving cytotoxicity via translational activation of ATF4.","volume":"3","author":"Ogbechi","year":"2018","journal-title":"Cell Death Dis."},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0002101","article-title":"Microbiological, histological, immunological, and toxin response to antibiotic treatment in the mouse model of Mycobacterium ulcerans disease.","volume":"7","author":"Sarfo","year":"2013","journal-title":"PLoS Negl. Trop. Dis."},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0001237","article-title":"Mycolactone diffuses into the peripheral blood of buruli ulcer patients\u2013implications for diagnosis and disease monitoring.","volume":"5","author":"Sarfo","year":"2011","journal-title":"PLoS Negl. Trop. Dis."},{"key":"B25","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1111\/cmi.12547","article-title":"Recent advances: role of mycolactone in the pathogenesis and monitoring of Mycobacterium ulcerans infection\/buruli ulcer disease.","volume":"18","author":"Sarfo","year":"2016","journal-title":"Cell. Microbiol."},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-14-202","article-title":"Kinetics of mycolactone in human subcutaneous tissue during antibiotic therapy for Mycobacterium ulcerans disease.","volume":"14","author":"Sarfo","year":"2014","journal-title":"BMC Infect. Dis."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1007\/s11095-013-1265-3","article-title":"Encapsulation of poorly soluble drugs in polymer-drug conjugates: effect of dual-drug nanoformulations on cancer therapy.","volume":"31","author":"Senanayake","year":"2014","journal-title":"Pharm. Res."},{"key":"B28","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/S1473-3099(06)70464-9","article-title":"Mycobacterium ulcerans infection: control, diagnosis, and treatment.","volume":"6","author":"Sizaire","year":"2006","journal-title":"Lancet. Infect. Dis."},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3390\/toxins9070227","article-title":"A bacterial toxin with analgesic properties: hyperpolarization of DRG neurons by mycolactone.","volume":"9","author":"Song","year":"2017","journal-title":"Toxins"},{"key":"B30","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1126\/science.354.6312.564","article-title":"The future of pain research.","volume":"354","author":"Stern","year":"2016","journal-title":"Science"},{"key":"B31","doi-asserted-by":"publisher","first-page":"e422","DOI":"10.1016\/S2214-109X(14)70223-2","article-title":"Clinical epidemiology of laboratory-confirmed Buruli ulcer in Benin: a cohort study.","volume":"2","author":"Vincent","year":"2014","journal-title":"Lancet Glob. Health"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2019.00378\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,12]],"date-time":"2019-04-12T04:28:34Z","timestamp":1555043314000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2019.00378\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,12]]},"references-count":31,"alternative-id":["10.3389\/fphar.2019.00378"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2019.00378","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,12]]},"article-number":"378"}}